Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

Heart experts concerned after Trump administration authorizes fruit-flavored e-cigarettes
This is the first time the FDA has authorized market access for non-tobacco, non-menthol electronic nicotine delivery systems.
Physicians chime in: Coronary plaque staging offers more precise cardiac patient management
As precision cardiology continues to evolve, the integration of advanced coronary computed tomography angiography (CCTA) and AI-driven analysis is fundamentally changing how we assess and manage coronary artery disease (CAD). Here is a closer look at how Heartflow Plaque Staging is leveraging Total Plaque Volume (TPV) to stratify patient risk.
SCCT President: Key trends in cardiac CT
As CCTA sees rapid adoption across cardiology, SCCT is working to address the education required to sustain the expansion.
TAVR or SAVR? Cardiologists and heart surgeons highlight the care that goes into each decision
When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.
Redo TAVR: Supra-annular, intra-annular valves linked to comparable outcomes
When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival.

First-in-Man Experience of Robotic-Assisted Transcatheter Edge-to-Edge Repair With Pure Echo Guidance

Cardiologists and surgeons perform world’s first robot-assisted TEER

A 62-year-old women presented with severe MR and recurrent heart failure episodes. Initial data suggest the procedure was a success.

Sunil Rao, MD, NYU, explains the DANGER-SHOCK trial at ACC 2024 and how it may help improve cardiogenic shock survival.

Cardiologist Sunil Rao highlights importance of DanGer Shock compared to other cardiogenic shock trials

Sunil Rao, MD, director of interventional cardiology at NYU Langone, says DanGer Shock is a "very, very important study" when it comes to the treatment of cardiogenic shock.

cardiologists going through the certification process

SCAI 2024 Scientific Sessions to focus on TAVR, PAD and other key trends in interventional cardiology

Interventional cardiologists from all over the world will gather for three days of educational sessions, late-breaking presentations, live cases and more. The festivities begin Thursday, May 2, in Long Beach, California.

doctor patient discharge after heart surgery

Next-day discharge after TAVR with a self-expanding valve: 4 key takeaways

Researchers explored STS/ACR data from nearly 30,000 TAVR patients, presenting their findings in the Journal of the American Heart Association.

Society of Thoracic Surgeons launches new risk calculators for SAVR after TAVR, other key heart surgeries

STS risk calculators are known as a go-to resource for cardiologists, surgeons and any other healthcare providers who manage the care of heart patients.

An 86-year-old patient is showing signs of improvement six months after receiving the world’s first implant of a new-look medical device for treating tricuspid regurgitation (TR), according to new data published in JACC: Cardiovascular Interventions.[1] The device in question, the Tricuspid Flow Optimizer, was developed by Triflo Cardiovascular, a U.S.-based biomedical company founded in 2017 by a team of structural heart specialists.

Cardiologists share update after world’s first implant of new optimizer device for tricuspid regurgitation

The Tricuspid Flow Optimizer was developed by Triflo Cardiovascular, a U.S.-based healthcare technology company founded by structural heart specialists.

Sarah Jane Rinehart, MD, director of cardiac imaging, Charleston Area Medical Center, Charleston West Virginia, as been using the FDA-cleared RoadMap artificial intelligence algorithm from HeartFlow in studies and in clinical used since it was cleared and said it helps cardiologists in several ways. #ACC #ACC24 #ACC2024 #Heartflow #AIhealth

AI improves CT assessments, boosts care for real-world heart patients

Automated AI-generated measurements combined with annotated CT images can improve treatment planning and help referring physicians and patients better understand their disease, explained Sarah Jane Rinehart, MD, director of cardiac imaging with Charleston Area Medical Center.

Cardiology groups share key update: ABMS seeking feedback on proposed Board of Cardiovascular Medicine

Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.

Cardiology Associations

Heart experts concerned after Trump administration authorizes fruit-flavored e-cigarettes

Physicians chime in: Coronary plaque staging offers more precise cardiac patient management

SCCT President: Key trends in cardiac CT

TAVR or SAVR? Cardiologists and heart surgeons highlight the care that goes into each decision

Redo TAVR: Supra-annular, intra-annular valves linked to comparable outcomes